Benoît Bertrand1, Angela Casini. 1. Dept. Pharmacokinetics, Toxicology and Targeting, Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, Groningen 9713 AV, The Netherlands. a.casini@rug.nl.
Abstract
From wedding rings on fingers to stained glass windows, by way of Olympic medals, gold has been highly prized for millennia. Nowadays, organometallic gold compounds occupy an important place in the field of medicinal inorganic chemistry due to their unique chemical properties with respect to gold coordination compounds. In fact, several studies have proved that they can be used to develop highly efficient metal-based drugs with possible applications in the treatment of cancer. This Perspective summarizes the results obtained for different families of bioactive organometallic gold compounds including cyclometallated gold(iii) complexes with C,N-donor ligands, gold(I) and gold(I/III) N-heterocyclic (NHC) carbene complexes, as well as gold(I) alkynyl complexes, with promising anticancer effects. Most importantly, we will focus on recent developments in the field and discuss the potential of this class of organometallic compounds in relation to their versatile chemistry and innovative mechanisms of action.
From wedding rings on fingers to stained glass windows, by way of Olympic medals, gold has been highly prized for millennia. Nowadays, organometallic gold compounds occupy an important place in the field of medicinal inorganic chemistry due to their unique chemical properties with respect to gold coordination compounds. In fact, several studies have proved that they can be used to develop highly efficient n class="Chemical">metal-based drugs with possible applications in the treatment of cancer. This Perspective summarizes the results obtained for different families of bioactive organometallic gold compounds including cyclometallated gold(iii) complexes with C,N-donor ligands, gold(I) and gold(I/III) N-heterocyclic (NHC) carbene complexes, as well as gold(I) alkynyl complexes, with promising anticancer effects. Most importantly, we will focus on recent developments in the field and discuss the potential of this class of organometallic compounds in relation to their versatile chemistry and innovative mechanisms of action.
Authors: Natalia Curado; Nora Giménez; Kirill Miachin; Mélanie Aliaga-Lavrijsen; Mike A Cornejo; Andrzej A Jarzecki; María Contel Journal: ChemMedChem Date: 2019-04-12 Impact factor: 3.466
Authors: Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini Journal: Toxicol Res (Camb) Date: 2019-09-20 Impact factor: 3.524
Authors: Benoît Bertrand; Anna Citta; Inge L Franken; Michel Picquet; Alessandra Folda; Valeria Scalcon; Maria Pia Rigobello; Pierre Le Gendre; Angela Casini; Ewen Bodio Journal: J Biol Inorg Chem Date: 2015-07-23 Impact factor: 3.358
Authors: C Ceresa; G Nicolini; S Semperboni; V Gandin; M Monfrini; F Avezza; P Alberti; A Bravin; M Pellei; C Santini; Guido Cavaletti Journal: Neurotox Res Date: 2018-01-17 Impact factor: 3.911
Authors: Benelita T Elie; Jacob Fernández-Gallardo; Natalia Curado; Mike A Cornejo; Joe W Ramos; María Contel Journal: Eur J Med Chem Date: 2018-10-17 Impact factor: 6.514